[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"cervicogenic-headache\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:cervicogenic-headache":27},{"pageToken":4,"total":5,"offset":6,"count":7,"results":8},null,27,0,25,[9,53,80,104,128,148,179,207,232,258,281,303,319,343,368,390,416,446,466,486,509,534,558,576,595],{"id":10,"slug":11,"hasResults":12,"nctId":13,"briefTitle":14,"officialTitle":15,"acronym":4,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":20,"enrollmentInfo":21,"targetDuration":4,"studyType":24,"phases":4,"briefSummary":25,"conditions":26,"keywords":29,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":41,"lastUpdatePostDateStruct":42,"startDateStruct":45,"completionDateStruct":47,"leadSponsor":49,"locationsCount":52},"100652615","physical-profile-of-cervicogenic-headache-comparison-with-neck-pain-and-healthy-controls-100652615",false,"NCT07776275","Physical Profile of Cervicogenic Headache: Comparison With Neck Pain and Healthy Controls","A Multidimensional Physical Profile of Cervicogenic Headache: A Cross-Sectional Comparison With Nonspecific Neck Pain and Healthy Controls","* Inclusion Criteria:\n* Aged 25 to 60 years\n* Able to provide written informed consent\n* Meeting the criteria for one of the following groups:\n* Cervicogenic headache: physician diagnosis according to the International Classification of Headache Disorders, 3rd edition, with symptoms lasting at least 3 months\n* Chronic nonspecific neck pain: neck pain lasting at least 6 months without headache\n* Healthy control: no neck pain or headache\n\nExclusion Criteria:\n\n* Receipt of physiotherapy for headache or neck pain during the previous 6 months\n* Diagnosis of a headache disorder other than cervicogenic headache, including migraine or tension-type headache, or a diagnosis of trigeminal neuralgia\n* History of cervical spine surgery or significant cervical trauma\n* Current or previous diagnosis of a tumor or cancer\n* Serious cardiovascular, cerebrovascular, hematological, metabolic, neurological, or psychiatric disorder\n* Rheumatoid arthritis\n* Congenital cervical abnormality\n* Cervical spondylolisthesis or cervical instability\n* Active infection\n* Temporomandibular joint dysfunction\n* Dizziness or visual disturbance accompanying headache\n* Any clinical red flag suggesting serious cervical pathology\n* Pregnancy or breastfeeding\n* Upper-extremity injury, surgery, or another condition affecting handgrip strength\n* Serious musculoskeletal disorder affecting cervical posture or muscle measurements\n* Inability to complete the questionnaire-based or instrument-based assessments",true,"ALL","25 Years","60 Years",{"count":22,"type":23},135,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to compare physical findings across three adult groups. Cervicogenic headache (CGH) is a headache linked to a problem in the neck. Neck pain may affect posture, muscle function, grip strength, and sensitivity to pressure. Researchers do not know whether CGH has a distinct pattern of these findings.\n\nThe main questions are:\n\n* Do posture, grip strength, muscle stiffness, elasticity, and pressure sensitivity differ among the groups?\n* Are any differences more closely associated with CGH than with neck pain?\n\nResearchers will compare adults ages 25 through 60. One group will include people with CGH lasting at least three months. Another group will include people with neck pain lasting at least six months. People in the neck pain group will have no headaches. Healthy participants will have no neck pain or headaches.\n\nResearchers will not provide treatment or change participants' usual care. Each participant will complete one study visit lasting about 15 minutes. Participants will:\n\n* Answer short questions about their health and pain\n* Stand while researchers measure their head and neck posture\n* Squeeze a device that measures grip strength\n* Complete brief tests of neck muscle stiffness and elasticity\n* Tell researchers when applied pressure first becomes painful\n\nResearchers will compare results across the three groups. The findings may guide future CGH assessment and treatment research.",[27,28],"Cervicogenic Headache","Chronic Neck Pain",[30,31,32,33,34,35,36,37,38,39],"physical profile","myotonometry","upper trapezius","muscle stiffness","logarithmic decrement","pressure pain threshold","handgrip strength","craniovertebral angle","tragus to wall distance","cross-sectional study","RECRUITING","2026-08-20",{"date":43,"type":44},"2026-08-21","ACTUAL",{"date":46,"type":44},"2026-04-21",{"date":48,"type":23},"2026-10-01",{"name":50,"class":51},"Istanbul Medipol University Hospital","OTHER",1,{"id":54,"slug":55,"hasResults":12,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":4,"eligibilityCriteria":59,"healthyVolunteers":12,"sex":18,"minAge":60,"maxAge":61,"enrollmentInfo":62,"targetDuration":4,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":4,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":4},"100652660","manual-therapy-vs-multicomponent-exercise-in-cervicogenic-headache-100652660","NCT07776093","Manual Therapy vs. Multicomponent Exercise in Cervicogenic Headache","Effects of Manual Therapy Versus Multicomponent Exercise on Sensorimotor Function, Suboccipital Muscle Thickness, and Central Sensitization in Cervicogenic Headache: A Double-Blind Randomized Controlled Trial","Inclusion Criteria:\n\n* Diagnosis of cervicogenic headache by a specialist physician,\n* Aged between 18 and 45 years,\n* Ability to read and write (literate),\n* Provision of signed informed consent to participate in the study.\n\nExclusion Criteria:\n\n* History of head or neck surgery,\n* History of spinal surgery,\n* History of severe cardiac conditions or cardiac surgery that contraindicates exercise,\n* History of ongoing or past malignancy,\n* Diagnosis of psychiatric disorders,\n* Diagnosis of migraine,\n* Diagnosis of fibromyalgia,\n* Having received medical (except analgesics), physical therapy, or other interventions (e.g., alternative medicine, massage therapy) for cervicogenic headache within the last 6 months,\n* Engaging in regular exercise or attending an exercise facility within the last 6 months,\n* Experiencing headaches strictly associated with the menstrual period,\n* Investigator decision for exclusion based on ethical or clinical grounds,\n* Communication problems interfering with evaluation and treatment.","18 Years","45 Years",{"count":63,"type":23},32,"INTERVENTIONAL",[66],"NA","The purpose of this study is to compare the effects of manual therapy and a multicomponent exercise program on suboccipital muscle thickness, joint position sense, pain, central sensitization, balance, and kinesiophobia in patients diagnosed with cervicogenic headache.\n\nCervicogenic headache is a common secondary headache originating from dysfunction in the upper cervical spine. Dysfunction in the deep neck muscles, impaired neck joint awareness, and heightened pain sensitivity (central sensitization) are frequently observed in these patients. While both manual therapy and targeted exercise are used in physiotherapy practice, evidence regarding their direct comparative effects on suboccipital muscle morphology and somatosensory parameters remains limited.\n\nParticipants will be randomly assigned to one of two treatment groups for a duration of 4 weeks (12 sessions total):\n\n1. Manual Therapy Group: Receives joint mobilization, myofascial release, trigger point release, and suboccipital distraction targeting the cervical region.\n2. Multicomponent Exercise Group: Receives deep cervical flexor strengthening, cervical proprioception training, head-eye coordination training, and progressive balance exercises.\n\nThe main questions the study aims to answer are:\n\n* Do manual therapy and multicomponent exercise improve suboccipital muscle thickness and cervical joint position sense in patients with cervicogenic headache?\n* Is there a significant difference between manual therapy and multicomponent exercise in reducing pain intensity, central sensitization, disability, and fear of movement (kinesiophobia)? It is hypothesized that both intervention protocols will yield significant clinical improvements, with specific synergistic adaptations in muscle structure, somatosensory system processing, and pain-related fear.",[27,69,70],"Proprioceptive Disorders","Neck Pain Musculoskeletal","NOT_YET_RECRUITING","2026-08-17",{"date":41,"type":44},{"date":75,"type":23},"2026-09-01",{"date":77,"type":23},"2027-03-31",{"name":79,"class":51},"Pamukkale University",{"id":81,"slug":82,"hasResults":12,"nctId":83,"briefTitle":84,"officialTitle":84,"acronym":4,"eligibilityCriteria":85,"healthyVolunteers":12,"sex":18,"minAge":86,"maxAge":60,"enrollmentInfo":87,"targetDuration":89,"studyType":24,"phases":4,"briefSummary":90,"conditions":91,"keywords":92,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":99,"completionDateStruct":101,"leadSponsor":102,"locationsCount":52},"100651688","correlation-between-forward-head-posture-cervical-muscles-endurance-and-proprioceptive-fuctions-in-cervicogenic-headache-among-late-adolescent-students-100651688","NCT07763886","CORRELATION BETWEEN FORWARD HEAD POSTURE, CERVICAL MUSCLES ENDURANCE, AND PROPRIOCEPTIVE FUCTIONS IN CERVICOGENIC HEADACHE AMONG LATE ADOLESCENT STUDENTS.","Inclusion Criteria:\n\nFifty-six junior students diagnosed with cervicogenic headache\n\n* Sudents from both sexes will participate in this study.\n* The students' ages will be ranged from 17 to 18 years.\n* All participants will be referred from neurologists\n* All participants will be free from any medical disease, visual or hearing problem.\n\nExclusion Criteria:\n\n* • Patients with a history of cervical spine surgery.\n\n  * Patients with Whiplash injury..\n  * Patients with any vestibular disorders.\n  * Patients with visual and hearing impairments.\n  * Patients with diabetes mellitus.","15 Years",{"count":88,"type":23},100,"1 Month","Forward Head Posture (FHP) is a common postural deviation characterized by anterior translation of the head relative to the trunk, which increases load on cervical muscles and joints. This postural change is associated with muscle fatigue, joint compression, and tension in cervical soft tissues, contributing to cervicogenic headache (Al-Mutairi et al., 20242; Koseoglu et al., 2023). The deep cervical flexor (DCF) muscles, especially the longus colli and longus capitis, are key stabilizers of the cervical spine, and weakness or fatigue of these muscles leads to overuse of superficial muscles such as the sternocleidomastoid and anterior scalene, creating an imbalance between deep and superficial systems. Diminished endurance of deep cervical flexors has been linked to forward head posture, impaired motor control, and persistent neck pain (Ismail et al., 2023). Cervical proprioception is crucial for accurate head position sense. Impaired cervical proprioception results in distorted information about head orientation, causing dizziness, incoordinated movement, and neck discomfort, and has been frequently observed in juniors with cervicogenic headache, increasing muscular strain and headache intensity. In the present study, therefore, we aim to investigate the correlation between FHP, cervical endurance, and proprioceptive function in junior students with cervicogenic headache",[27],[93,94,95],"Forward Head Posture","Headache","Cervicogenic headache","2026-08-09",{"date":98,"type":44},"2026-08-13",{"date":100,"type":23},"2026-08-10",{"date":75,"type":23},{"name":103,"class":51},"Delta University for Science and Technology",{"id":105,"slug":106,"hasResults":12,"nctId":107,"briefTitle":108,"officialTitle":109,"acronym":4,"eligibilityCriteria":110,"healthyVolunteers":12,"sex":18,"minAge":60,"maxAge":111,"enrollmentInfo":112,"targetDuration":4,"studyType":64,"phases":114,"briefSummary":115,"conditions":116,"keywords":117,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":119,"lastUpdatePostDateStruct":120,"startDateStruct":122,"completionDateStruct":124,"leadSponsor":126,"locationsCount":4},"100648674","effects-of-graston-versus-myofascial-release-technique-in-patients-with-cervicogenic-headache-100648674","NCT07724639","Effects of Graston Versus Myofascial Release Technique in Patients With Cervicogenic Headache","Effects of Graston Versus Myofascial Release Technique on Pain, Range of Motion and Functional Disability in Patients With Cervicogenic Headache","Inclusion Criteria:\n\n* Males and females between age 18-40 years \\[A30.1\\]of age with Cervicogenic Headache\n* Diagnosed with Cervicogenic headache according to ICHD-3 criteria (3)\n* Presence of active myofascial trigger points in the SCM and upper trapezius and subocvcipital levator scapuli (confirmed \\[A31.1\\]via palpation and referred pain) simens \\[A32.1\\]criteria\n* Positive Cervical Flexion Rotation Test\n\nExclusion Criteria:\n\n* Any history of cervical trauma, fracture, or recent surgery.\n* Diagnosis of migraine, tension-type headache, or cluster headache (9).\n* Any cervical spine pathology e.g. cervical myelopathies and arthropathies.\n* Pregnant or lactating women.\n* Skin conditions or open wounds that contraindicate use of Graston tools e.g. open wounds, skin infections and burns etc.","40 Years",{"count":113,"type":23},48,[66],"Cervicogenic Headache (CGH) is a painful condition that has pronounced impacts on quality and activity of daily lives. It is often associated with decreased mobility, muscular tightness, and postural deviations. When neck muscles become tight, weak, or irritated, they change the way the neck moves and put pressure on nearby joints and nerves. This pressure delivers pain signals to the head, causing a Cervicogenic headache.",[27],[118],"Cervicogenic Headache, Graston Technique, Neck Disability Index, Numeric Pain Rating Scale, Myofascial Release Therapy, Range of Motion","2026-07-23",{"date":121,"type":44},"2026-07-24",{"date":123,"type":23},"2026-07",{"date":125,"type":23},"2026-12-30",{"name":127,"class":51},"Riphah International University",{"id":129,"slug":130,"hasResults":12,"nctId":131,"briefTitle":132,"officialTitle":132,"acronym":4,"eligibilityCriteria":133,"healthyVolunteers":12,"sex":18,"minAge":60,"maxAge":61,"enrollmentInfo":134,"targetDuration":4,"studyType":64,"phases":136,"briefSummary":137,"conditions":138,"keywords":4,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":139,"lastUpdatePostDateStruct":140,"startDateStruct":142,"completionDateStruct":144,"leadSponsor":146,"locationsCount":52},"100633387","comparative-effects-of-eye-cervical-re-education-exercises-and-pressure-biofeedback-training-of-deep-cervical-flexors-in-cervicogenic-headache-100633387","NCT07526025","Comparative Effects Of Eye-Cervical Re-Education Exercises And Pressure Biofeedback Training Of Deep Cervical Flexors In Cervicogenic Headache","Inclusion Criteria:\n\n* Age 18 to 45 years\n* Both genders\n* Unilateral neck pain and referred headache\n* Headache is precipitated by neck movements or sustained positions.\n* Positive cervical flexion rotation test\n* Headache reproduced with provocation of the involved upper cervical segments.\n* Restricted upper cervical segmental mobility.\n\nExclusion Criteria:\n\n* • Cervical radiculopathy\n\n  * Known or suspected vestibular disorders such as BBPV (Benign Paroxysmal Positional Vertigo), vestibular neuritis, meniere's disease, labyrinthitis\n  * Visual problems such as occipital neuralgia\n  * History of traumatic neck injury\u002Fsurgery or cervical instability\n  * Rheumatoid arthritis\n  * Osteoporosis\n  * Metabolic disorders\n  * Spinal infection or tumors\n  * Vertebrobasilar insufficiency\n  * Other headache types such as tension headache, migraine etc",{"count":135,"type":23},34,[66],"Cervicogenic headache (CGH) is a secondary headache that originates from dysfunction in the upper cervical spine, particularly the atlanto-occipital and C1-C3 segments, and is perceived in one or more regions of the head and\u002For face. The underlying mechanism involves convergence of cervical and trigeminal afferents in the trigeminocervical nucleus. Structures innervated by the C1, C2, and C3 spinal nerves are capable of producing referred pain to the head. CGH is relatively common, accounting for approximately 15-20% of all chronic headaches. It typically worsens with neck movement and is often associated with limited cervical range of motion. One of the key impairments in individuals with CGH is disrupted cervical sensorimotor control, particularly affecting proprioception and deep cervical muscle coordination. Physical therapy is widely recognized as the first-line treatment for CGH, with emerging evidence supporting interventions aimed at improving cervical proprioception and neuromuscular control. This study aims to compare the effectiveness of two sensorimotor-based physical therapy approaches-eye-cervical re-education and pressure biofeedback training of deep cervical flexors (DCF)-in patients with CGH. The primary outcomes include pain intensity, functional disability, cervical range of motion (ROM), and cervical joint position sense (proprioception). Participants will be recruited using purposive sampling from Fauji Foundation Hospital and Foundation University College of Physical Therapy (FUCP), Islamabad. After providing written informed consent, eligible participants will be randomized into two groups. Group 1 will receive conventional physical therapy along with eye-cervical re-education exercises, while Group 2 will receive conventional therapy combined with pressure biofeedback DCF training. Data will be collected at baseline and after the 10th treatment session to assess within- and between-group changes in the outcome measures. This study aims to inform evidence-based physical therapy practice in the management of cervicogenic headache.",[27],"2026-05-18",{"date":141,"type":44},"2026-05-20",{"date":143,"type":23},"2026-05-19",{"date":145,"type":23},"2026-06-15",{"name":147,"class":51},"Foundation University Islamabad",{"id":149,"slug":150,"hasResults":12,"nctId":151,"briefTitle":152,"officialTitle":153,"acronym":154,"eligibilityCriteria":155,"healthyVolunteers":12,"sex":18,"minAge":60,"maxAge":156,"enrollmentInfo":157,"targetDuration":4,"studyType":64,"phases":159,"briefSummary":160,"conditions":161,"keywords":164,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":46,"lastUpdatePostDateStruct":171,"startDateStruct":173,"completionDateStruct":175,"leadSponsor":177,"locationsCount":52},"100635683","osteopathic-manipulative-treatment-vs-physiotherapy-in-cervicocranial-dysfunction-100635683","NCT07555873","Osteopathic Manipulative Treatment vs Physiotherapy in Cervicocranial Dysfunction","Comparative Effects of Osteopathic Manipulative Treatment and Standard Physiotherapy on Dizziness, Headache Impact, Neck Disability, and Psychological Stress in Patients With Cervicocranial Dysfunction: A Randomized Controlled Trial","OMT-CCD","Inclusion Criteria:\n\n* Participants will be eligible for inclusion in the study if they meet the following criteria:\n\n  * Age between 18 and 65 years.\n  * Presence of cervicocranial symptoms for at least three months, indicating a chronic condition.\n  * Neck pain with or without associated headache.\n  * Dizziness associated with neck movement or cervical position.\n  * Clinical findings consistent with cervicocranial dysfunction, based on clinical examination.\n  * Ability to understand and complete standardized clinical questionnaires used in the study.\n  * Willingness to participate in the study and provision of written informed consent.\n\nExclusion Criteria:\n\n* Participants will be excluded from the study if they present with any of the following conditions:\n\n  * Clinically confirmed vestibular disorders.\n  * Central neurological disorders that may influence dizziness or balance.\n  * Recent severe trauma to the cervical spine.\n  * History of cervical spine surgery.\n  * Systemic inflammatory diseases or serious spinal pathologies.\n  * Presence of red flags related to the cervical spine identified during clinical screening.\n  * Participation in concurrent intensive physiotherapy or rehabilitation treatment during the study period.","65 Years",{"count":158,"type":23},50,[66],"This study aims to compare the effects of osteopathic manipulative treatment and standard physiotherapy in patients with cervicocranial dysfunction. The study will evaluate outcomes including dizziness, headache impact, neck disability, and psychological stress.\n\nParticipants will be randomly assigned to one of two groups: osteopathic treatment or standard physiotherapy. The interventions will be applied over a defined treatment period, and outcomes will be measured before and after the intervention.\n\nThe purpose of this study is to determine which approach is more effective in improving symptoms and functional outcomes in patients with cervicocranial dysfunction.",[27,162,70,163],"Dizziness","Cervicocranial Dysfunction",[165,166,167,168,169,170],"osteopathic manipulation treatmant","manual therapy","physiotherapy","RCT","cervicogenic headache","dizziness rehabilitation",{"date":172,"type":44},"2026-04-29",{"date":174,"type":23},"2026-05-01",{"date":176,"type":23},"2026-09-30",{"name":178,"class":51},"Burim Peli",{"id":180,"slug":181,"hasResults":12,"nctId":182,"briefTitle":183,"officialTitle":183,"acronym":4,"eligibilityCriteria":184,"healthyVolunteers":12,"sex":18,"minAge":60,"maxAge":156,"enrollmentInfo":185,"targetDuration":4,"studyType":64,"phases":187,"briefSummary":188,"conditions":189,"keywords":190,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":197,"lastUpdatePostDateStruct":198,"startDateStruct":200,"completionDateStruct":202,"leadSponsor":204,"locationsCount":52},"100632032","comparison-of-the-eficacy-of-mulligan-mobilization-and-myofascial-release-in-patients-with-cervicogenic-headache-100632032","NCT07508410","Comparison of the Eficacy of Mulligan Mobilization and Myofascial Release in Patients With Cervicogenic Headache","Inclusion criteria:\n\n* Individuals aged 18-65\n* Having experienced neck or headache for 3 months\n* Meeting the diagnostic criteria for cervicogenic headache;\n\n  * Unilateral pain\n  * Reduced range of motion in the neck\n  * Ipsilateral shoulder discomfort\n  * Ipsilateral arm discomfort\n  * Pain that worsens with different neck movements and is painful on palpation\n\nExclusion criteria:\n\n* Migraine\n* Cluster headache\n* Cervical radiculopathy\n* Entrapment neuropathy\n* Myelopathy\n* Rheumatoid arthritis\n* Undergoing cervical spinal surgery\n* Pregnant women\n* Those who received physical therapy within 6 months\n* Those with a history of major psychiatric illness\n* Those with a history of uncontrolled systemic diseases (cardiovascular, pulmonary, hepatic, renal, hematological)\n* Those with a history of uncontrolled systemic endocrine diseases (dm, hyperthyroidism)",{"count":186,"type":23},90,[66],"Cervicogenic headache (CBH) is defined as a headache caused by a disorder in the cervical spine, bones, discs, or soft tissue elements, which is also accompanied by neck pain.\n\nUnilateral, non-reversible oculo, fronto, temporal pain, pain that increases with poor neck positioning and incorrect neck movements, and may be seen with restricted movement in the upper cervical and occiput regions.\n\nThe aim of this thesis is to compare the effectiveness of Mulligan mobilization technique and myofascial release methods used in the treatment of cervicogenic headache through a prospective clinical study.",[27],[191,192,193,194,195,196],"Neck pain","Massage therapy","Musculoskeletal diseases","Musculoskeletal manipulation","Rehabilitation","Complementary therapies","2026-03-30",{"date":199,"type":44},"2026-04-02",{"date":201,"type":44},"2025-12-01",{"date":203,"type":23},"2026-12-01",{"name":205,"class":206},"Konya Beyhekim Training and Research Hospital","OTHER_GOV",{"id":208,"slug":209,"hasResults":12,"nctId":210,"briefTitle":211,"officialTitle":211,"acronym":212,"eligibilityCriteria":213,"healthyVolunteers":12,"sex":18,"minAge":60,"maxAge":214,"enrollmentInfo":215,"targetDuration":4,"studyType":64,"phases":217,"briefSummary":218,"conditions":219,"keywords":220,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":223,"lastUpdatePostDateStruct":224,"startDateStruct":226,"completionDateStruct":228,"leadSponsor":230,"locationsCount":4},"100621691","impact-of-adding-instrument-assisted-soft-tissue-mobilization-to-mulligan-therapy-in-patients-with-cervicogenic-headache-100621691","NCT07373912","Impact of Adding Instrument-assisted Soft Tissue Mobilization to Mulligan Therapy in Patients With Cervicogenic Headache","CGH","Inclusion Criteria:\n\n-Unilateral CGH presentation\n\n* Age group above 18 years' old\n* History of chronic CGH (\\>3 months)\n* CGH owing to cervical spine (neck) dysfunction\n* Reduced cervical motion\n* Neck stiffness and movement restriction\n\nExclusion Criteria:\n\n* Participants with other types of headache (migraine headache)\n* Headache owing to other causes (sinus, tumor, neural, and tempero-mandibular joint issues)\n* Any contraindications to manual and manipulative therapy (fracture, instability, osteoporosis and neural symptoms)\n* Taking analgesics or corticosteroids and migraine-specific medications, such as triptans\n* Metastasis\n* Cardiac conditions (stroke and syncope)\n* Neurological conditions (radiculopathy, myelopathy)","70 Years",{"count":216,"type":23},60,[66],"this study will be conducted to investigate the impact of adding Instrument assisted soft tissue mobilization technique to mulligan therapy in patients with cervicogenic headache",[27],[221,222],"Instrument Assisted Soft Tissue Mobilization","mulligan therapy","2026-01-21",{"date":225,"type":44},"2026-01-28",{"date":227,"type":23},"2026-02-01",{"date":229,"type":23},"2026-07-01",{"name":231,"class":51},"Cairo University",{"id":233,"slug":234,"hasResults":12,"nctId":235,"briefTitle":236,"officialTitle":236,"acronym":4,"eligibilityCriteria":237,"healthyVolunteers":12,"sex":18,"minAge":60,"maxAge":238,"enrollmentInfo":239,"targetDuration":4,"studyType":24,"phases":4,"briefSummary":240,"conditions":241,"keywords":244,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":249,"lastUpdatePostDateStruct":250,"startDateStruct":252,"completionDateStruct":254,"leadSponsor":256,"locationsCount":52},"100621482","relationship-between-upper-cervical-mobility-and-temporomandibular-joint-range-of-motion-in-patients-with-temporomandibular-disorders-100621482","NCT07371195","Relationship Between Upper Cervical Mobility and Temporomandibular Joint Range of Motion in Patients With Temporomandibular Disorders","Inclusion Criteria:\n\n* Medically stable individuals who consent to participate in the study.\n* Age between 18 and 50 years.\n* Both male and female participants.\n* Patients diagnosed with temporomandibular joint (TMJ) dysfunction for at least three months.\n\nExclusion Criteria:\n\n* Presence of systemic diseases.\n* Body mass index (BMI) greater than 30 kg\u002Fm².\n* Pregnancy.\n* Recent physical therapy for cervical spine disorders, headaches, or temporomandibular dysfunction.\n* Cervical radiculopathy or other neurological disorders.\n* History of trauma or major psychological problems.\n* Generalized joint hypermobility.\n* Down syndrome.","50 Years",{"count":158,"type":23},"Upper cervical spine mobility plays a crucial role in temporomandibular joint (TMJ) function. This observational study investigates the relationship between upper cervical spine mobility and TMJ range of motion in patients diagnosed with temporomandibular disorders (TMD). Cervical hypomobility may restrict mandibular movement and contribute to TMJ dysfunction through shared biomechanical and neuromuscular mechanisms.",[242,243,27],"Temporomandibular Disorders (TMD)","Temporomandibular Joint Dysfunction Syndrome",[245,246,247,248],"Temporomandibular Joint","Temporomandibular Disorders","Upper Cervical Spine","Cervical Mobility","2026-01-19",{"date":251,"type":44},"2026-01-27",{"date":253,"type":23},"2026-02",{"date":255,"type":23},"2026-09",{"name":257,"class":51},"Deraya University",{"id":259,"slug":260,"hasResults":12,"nctId":261,"briefTitle":262,"officialTitle":263,"acronym":264,"eligibilityCriteria":265,"healthyVolunteers":12,"sex":18,"minAge":60,"maxAge":4,"enrollmentInfo":266,"targetDuration":4,"studyType":64,"phases":267,"briefSummary":268,"conditions":269,"keywords":271,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":274,"lastUpdatePostDateStruct":275,"startDateStruct":277,"completionDateStruct":278,"leadSponsor":279,"locationsCount":52},"100621087","effectiveness-of-third-occipital-nerve-pulsed-radiofrequency-in-cervicogenic-headache-100621087","NCT07366060","Effectiveness of Third Occipital Nerve Pulsed Radiofrequency in Cervicogenic Headache","Evaluation of the Effectiveness of Third Occipital Nerve Pulsed Radiofrequency Treatment in Patients With Cervicogenic Headache","TON-PRF-CH","Inclusion Criteria:\n\n* Age 18 years or older\n* Diagnosis of cervicogenic headache according to the International Classification of Headache Disorders, 3rd edition (ICHD-3)\n* Availability of cranial and cervical spine imaging\n* At least 5 headache days per month\n* Inadequate response to pharmacological and\u002For physical therapy treatments\n* Ability to understand and provide written informed consent\n* Positive response to ultrasound-guided diagnostic third occipital nerve block, defined as at least 50% reduction in pain intensity or patient-reported meaningful improvement\n\nExclusion Criteria:\n\n* Secondary headache disorders other than cervicogenic headache according to ICHD-3\n* Signs or symptoms of cervical nerve root irritation and\u002For spinal stenosis\n* Sensory deficit in the greater occipital nerve dermatome\n* Cranio-cervical structural defects or anatomical abnormalities at or near the target site\n* Local or systemic infection\n* Non-pharmacological headache treatment within the last 3 months (e.g., physical therapy, botulinum toxin A, acupuncture, ozone therapy, cognitive behavioral therapy)\n* Pregnancy or suspected pregnancy\n* Known allergy to local anesthetic agents\n* History of malignancy\n* Known organic disease of the brain or spinal cord\n* History of cranial or cervical surgery within the last 12 months\n* Bleeding or coagulation disorders or use of oral anticoagulant therapy\n* Comorbid conditions that may cause headache (e.g., uncontrolled hypertension, intracranial lesions)\n* Conditions that may interfere with treatment adherence or outcome assessment (e.g., psychiatric disorders, dementia)\n* Request for re-treatment due to development of contralateral pain or other pain conditions during follow-up\n* Refusal to undergo the intervention or withdrawal of consent at any stage of the study",{"count":7,"type":23},[66],"Cervicogenic headache is a secondary headache disorder originating from cervical spine structures and is frequently associated with chronic pain, functional limitation, and impaired quality of life. The third occipital nerve, which innervates the C2-3 zygapophyseal joint, plays an important role in the pathophysiology of cervicogenic headache.\n\nPulsed radiofrequency is a minimally invasive interventional pain management technique that modulates nociceptive transmission without causing permanent neural damage. Although third occipital nerve pulsed radiofrequency is increasingly used in clinical practice, prospective data evaluating its clinical effectiveness and safety remain limited.\n\nThe aim of this prospective, single-center study is to evaluate the effectiveness and safety of ultrasound-guided third occipital nerve pulsed radiofrequency treatment in patients diagnosed with cervicogenic headache. Pain intensity, headache characteristics, analgesic consumption, and patient-reported outcomes will be assessed before treatment and during follow-up. The results of this study are expected to contribute to clinical evidence supporting interventional treatment strategies for cervicogenic headache.",[27,270],"Third Occipital Nerve",[169,272,270,273],"Pulsed Radiofrequency","TON PRF","2026-01-17",{"date":276,"type":44},"2026-01-26",{"date":227,"type":23},{"date":75,"type":23},{"name":280,"class":51},"Ankara City Hospital Bilkent",{"id":282,"slug":283,"hasResults":12,"nctId":284,"briefTitle":285,"officialTitle":286,"acronym":4,"eligibilityCriteria":287,"healthyVolunteers":12,"sex":18,"minAge":60,"maxAge":156,"enrollmentInfo":288,"targetDuration":4,"studyType":64,"phases":290,"briefSummary":291,"conditions":292,"keywords":4,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":295,"lastUpdatePostDateStruct":296,"startDateStruct":298,"completionDateStruct":299,"leadSponsor":301,"locationsCount":52},"100619677","clinical-study-of-myofascial-trigger-pointsmtrps-injection-in-the-treatment-of-chronic-cervicogenic-headache-100619677","NCT07347730","Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Chronic Cervicogenic Headache","Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Chronic Musculoskeletal Pain(CMP), Chronic Migraine and Cervicogenic Headache","Inclusion Criteria:\n\n* Diagnosed with cervicogenic headache by at least two pain specialists or neurologists;\n* Disease duration of at least 3 months;\n* Age between 18 and 65 years;\n* Numerical Rating Scale (NRS) score ≥ 3 despite conservative pharmacological treatment;\n* Signed informed consent form.\n\nExclusion Criteria:\n\n* History of allergy to trial medications such as corticosteroids;\n* Alcohol abuse; long-term use of opioids (exceeding 2 weeks or more than 3 days per week for over 1 month); suspected use of sedative or analgesic medications; patients on long-term steroid therapy;\n* Severe neurological disorders, significant hepatic or renal dysfunction, heart failure, coagulation abnormalities, gastric ulcer, diabetes, inflammatory rheumatic diseases, etc.;\n* Inability to use pain assessment scales;\n* Presence of local or systemic infection;\n* Pregnant or lactating patients.",{"count":289,"type":23},1036,[66],"Chronic cervicogenic headache is a common disease in China, with a high incidence among the elderly, and has a significant impact on patients' quality of life. Currently, both domestic and international studies have confirmed that glucocorticoid injection at myofascial trigger points(MTrPs) can alleviate patients' pain symptoms. MTrPs injection is safe and easy to operate, and can improve the clinical management efficiency of patients with chronic cervicogenic headache. Therefore, we designed a prospective, randomized controlled, blinded outcome, non-inferiority study to compare the long-term clinical efficacy of glucocorticoid injection at myofascial trigger points and greater occipital nerve block injection in treating chronic cervicogenic headache. Patients will be randomly divided into two groups and receive either glucocorticoid injection at MTrPs or dorsal rami blocks of C2 spinal nerves. After treatment, patients will be followed up for 2 years. Their NRS scores, attack frequency, attack duration, HIT-6 scores, Patient Global Impression of Change(PGIC) scale, and adverse reactions will be recorded at 2 weeks, 4 weeks, 8 weeks, 12 weeks, and 24 weeks. If the results indicate that the clinical efficacy of myofascial trigger point injection for chronic cervicogenic headache is not inferior to that of injection at intra-articular injection, it will provide a safe and simple treatment option that is easy to promote for patients who do not respond to conservative treatment.",[293,27,294],"Myofascial Trigger Points","Dorsal Root Ganglion","2026-01-11",{"date":297,"type":44},"2026-01-16",{"date":201,"type":44},{"date":300,"type":23},"2027-06-01",{"name":302,"class":51},"Beijing Tiantan Hospital",{"id":304,"slug":305,"hasResults":12,"nctId":306,"briefTitle":307,"officialTitle":286,"acronym":4,"eligibilityCriteria":308,"healthyVolunteers":12,"sex":18,"minAge":61,"maxAge":4,"enrollmentInfo":309,"targetDuration":4,"studyType":64,"phases":310,"briefSummary":311,"conditions":312,"keywords":4,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":295,"lastUpdatePostDateStruct":315,"startDateStruct":316,"completionDateStruct":317,"leadSponsor":318,"locationsCount":52},"100619623","clinical-study-of-myofascial-trigger-pointsmtrps-injection-in-the-treatment-of-knee-osteoarthritisoa-100619623","NCT07347028","Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Knee Osteoarthritis(OA)","Inclusion Criteria:\n\n* Diagnosis of knee osteoarthritis with radiographic evidence of osteoarthritis (Kellgren-Lawrence grade 1-4) confirmed by at least two orthopedic surgeons, pain specialists, or general practitioners, with physical examination confirming at least one myofascial trigger point;\n* Disease duration exceeding 3 months;\n* Age ≥ 45 years;\n* Numerical Rating Scale (NRS) score ≥ 3 points despite prior conservative pharmacological treatment;\n* Signed informed consent form.\n\nExclusion Criteria:\n\n* History of allergy to trial medications such as corticosteroids;\n* Alcohol abuse; long-term use of opioids (exceeding 2 weeks or more than 3 days per week for over 1 month); suspected use of sedative or analgesic medications; patients on long-term steroid therapy;\n* Severe neurological disorders, significant hepatic or renal dysfunction, heart failure, coagulation abnormalities, gastric ulcer, diabetes, inflammatory rheumatic diseases, etc.;\n* Intra-articular injection within the past 6 months or planned joint replacement surgery;\n* Inability to use pain assessment scales;\n* Presence of local or systemic infection;\n* Pregnant or lactating patients.",{"count":289,"type":23},[66],"Chronic musculoskeletal pain (CMP) is a common disease in China, with a high incidence among the elderly, and has a significant impact on patients' quality of life. Knee osteoarthritis is a common type of CMP. Currently, both domestic and international studies have confirmed that glucocorticoid injection at myofascial trigger points(MTrPs) can alleviate patients' pain symptoms. MTrPs injection is safe and easy to operate, and can improve the clinical management efficiency of patients with knee osteoarthritis. Therefore, we designed a prospective, randomized controlled, blinded outcome, non-inferiority study to compare the long-term clinical efficacy of glucocorticoid injection at myofascial trigger points and complex intra-articular injection in treating knee osteoarthritis. Patients will be randomly divided into two groups and receive either glucocorticoid injection at MTrPs or joint cavities. After treatment, patients will be followed up for 2 years. Their NRS scores, WOMAC scores, Patient Global Impression of Change(PGIC) scale, and adverse reactions will be recorded at 2 weeks, 4 weeks, 8 weeks, 12 weeks, and 24 weeks. If the results indicate that the clinical efficacy of myofascial trigger point injection for knee osteoarthritis is not inferior to that of injection at intra-articular injection, it will provide a safe and simple treatment option that is easy to promote for patients who do not respond to conservative treatment.",[293,313,27,314],"Migraine","Chronic Musculoskeletal Pain",{"date":297,"type":44},{"date":201,"type":44},{"date":300,"type":23},{"name":302,"class":51},{"id":320,"slug":321,"hasResults":12,"nctId":322,"briefTitle":323,"officialTitle":323,"acronym":324,"eligibilityCriteria":325,"healthyVolunteers":12,"sex":18,"minAge":60,"maxAge":156,"enrollmentInfo":326,"targetDuration":4,"studyType":64,"phases":328,"briefSummary":329,"conditions":330,"keywords":331,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":334,"lastUpdatePostDateStruct":335,"startDateStruct":337,"completionDateStruct":339,"leadSponsor":341,"locationsCount":52},"100605491","therapeutic-efficacy-of-different-wavelengths-of-low-level-laser-therapy-in-the-treatment-of-cervicogenic-headache-100605491","NCT07163208","Therapeutic Efficacy of Different Wavelengths of Low-Level Laser Therapy in the Treatment of Cervicogenic Headache","WELL","Inclusion Criteria:\n\n* Patients aged 18-65 years diagnosed with cervicogenic headache based on the International Classification of Headache Disorders (ICHD-3) criteria.\n* Persistent headaches for at least 3 months.\n* No previous exposure to low-level laser therapy (LLLT).\n\nExclusion Criteria:\n\n* Patients with other primary headache disorders (e.g., migraine, tension-type headache).\n* History of cervical spine surgery.\n* Pregnant or lactating women.\n* Patients with a history of photosensitivity or taking photosensitizing medications.",{"count":327,"type":23},150,[66],"This study tests if low-level laser therapy (LLLT) with different light wavelengths can help people with cervicogenic headache, a type of headache caused by neck problems. Adults aged 18-65 with this headache for at least 3 months will try one of three LLLT treatments (675nm, 820nm, or a mix of wavelengths) along with regular physical therapy like stretching and exercises. The study will check pain levels, how often headaches happen, neck movement, disability, and quality of life over 6 weeks, with follow-ups at 3 and 6 months. the investigators want to find the best LLLT option to reduce headache symptoms safely.",[27],[27,332,333],"Low-Level Laser Therapy","Neck Pain","2025-09-15",{"date":336,"type":44},"2025-09-19",{"date":338,"type":44},"2024-09-05",{"date":340,"type":23},"2025-10-05",{"name":342,"class":51},"University of Lahore",{"id":344,"slug":345,"hasResults":12,"nctId":346,"briefTitle":347,"officialTitle":348,"acronym":212,"eligibilityCriteria":349,"healthyVolunteers":12,"sex":350,"minAge":60,"maxAge":156,"enrollmentInfo":351,"targetDuration":4,"studyType":64,"phases":353,"briefSummary":356,"conditions":357,"keywords":4,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":359,"lastUpdatePostDateStruct":360,"startDateStruct":362,"completionDateStruct":364,"leadSponsor":366,"locationsCount":52},"100486691","phase-1-treating-chronic-cervicogenic-head-and-neck-pain-100486691","NCT05617365","Treating Chronic Cervicogenic Head and Neck Pain","Treating Chronic Cervicogenic Head and Neck Pain With Osteopathic Manipulation and Exercise Therapy","Inclusion Criteria: Females diagnosed with chronic cervicogenic headache.\n\nExclusion Criteria:\n\n* Have you been involved in a rear-end motor vehicle accident within the past 3 years?\n* Have you had spinal surgery performed on your neck?\n* Do you have a pinched nerve in the neck that produces pain radiating down your arm.\n* Have you been diagnosed with diseases such as rheumatoid arthritis, lupus, or ankylosing spondylitis.\n* Do you have ongoing central nervous system pathology such as hemiparesis, cervical radiculopathy, spondylolisthesis grade III or IV, central nervous system causes of balance \\& coordination deficits, orthostatic hypotension, vestibular disorders, pregnancy, recent spinal fractures, moderate to severe traumatic brain injury.","FEMALE",{"count":352,"type":23},30,[354,355],"PHASE1","PHASE2","The primary aim is to test the combined effectiveness of OMT and targeted head exercise (THE) to achieve a significant decrease in headache measures of frequency, intensity, and duration in a Treatment group when compared to a Control group whose members receive only standard medical care. A parallel, 2-arm, longitudinal, randomized controlled trial (RCT) will focus upon female patients (18 to 75 years of age) who have been diagnosed with chronic cervicogenic headache (CeH) based upon a differential diagnosis that includes classification according to the International Headache Society Classification IHSD 3rd Edition, reproduction of referred headache resulting from manual pressure over the upper cervical regions, and objective MRI findings. It is estimated that a sample size of 30 will provide sufficient statistical power (79%) to detect an intervention effect that corresponds to a clinically meaningful recovery (60%).\n\nCeH is classified as a secondary headache disorder because the headache pain is a consequence of injury to, or disease of, the bony and\u002For soft tissues of the upper cervical spine. It has been reported that some patients diagnosed with CeH demonstrate atrophy and\u002For fatty infiltration (FI) of the RCPm muscles on MRI. FI and\u002For a reduction in the cross-sectional area (CSA) of active muscle would not be expected to be the direct cause of chronic headache, but either or both could prevent muscles from generating normal physiologic levels of force. It has been shown that there is a functional connection between the pain sensitive dura mater and RCPm muscles and it is known that mechanical stretching of the dura mater results in referred headache.\n\nWhile FI and\u002For a reduction in the CSA of active muscle would not be expected to be the direct cause of chronic headache, it is known that muscle pathology will result in functional deficits. It is proposed that pathology in RCPm muscles will compromise the normal functional relationship between the RCPm and the dura mater and result in referred head and neck pain. It is predicted that at the end of the study, the Treatment group will show a significant decrease in headache measures that will be accompanied by a significant increase in CSA and a significant decrease in FI on MRI, and restoration of a normal head posture that will not be seen in the Control group.\n\nThe proposed study is unique in that we are proposing both a mechanism and a source for some instances of CeH. By testing the effectiveness of specific interventions to address a specific pathology within a specific headache population, and by restricting the study cohort to female subjects presenting with CeH, this study will increase the ability to detect a significant change in the outcomes by increasing the power of the statistical analysis.",[27,358],"Neck Pain, Posterior","2025-09-13",{"date":361,"type":44},"2025-09-18",{"date":363,"type":44},"2022-09-01",{"date":365,"type":23},"2026-06-01",{"name":367,"class":51},"Michigan State University",{"id":369,"slug":370,"hasResults":12,"nctId":371,"briefTitle":372,"officialTitle":372,"acronym":212,"eligibilityCriteria":373,"healthyVolunteers":12,"sex":18,"minAge":374,"maxAge":20,"enrollmentInfo":375,"targetDuration":4,"studyType":64,"phases":376,"briefSummary":377,"conditions":378,"keywords":379,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":382,"lastUpdatePostDateStruct":383,"startDateStruct":385,"completionDateStruct":387,"leadSponsor":389,"locationsCount":4},"100599623","impact-of-adding-integrated-neuromuscular-inhibition-technique-to-postural-correction-exercises-in-patients-with-cervicogenic-headache-100599623","NCT07086898","Impact of Adding Integrated Neuromuscular Inhibition Technique to Postural Correction Exercises in Patients With Cervicogenic Headache","Inclusion Criteria:\n\n* 20 to 60 years old patient with unilaterally of the head pain\n* pain triggered by external pressure over the upper cervical joints (c1-c3)\n* pain elicited by the neck movements, and\u002For sustained awkward positions with reduced neck ROM\n* headache intensity pain score of at least 20mm on the Visual analogue scale (VAS)\n* headache frequency of at least once a week for at least 3 months\n* minimum neck disability index score of 10 points or greater\n\nExclusion Criteria:\n\n* Migraine, tension- type headache, tumor, osteoporosis, fracture, rheumatoid arthritis and metabolic diseases.\n* Prolonged history of steroid use.\n* Resting blood pressure greater than 140\u002F90 mmhg.\n* cervical spinal stenosis, diminished sensation and central nervous system involvement,\n* previous","20 Years",{"count":186,"type":23},[66],"this study will be conducted to investigate the impact of adding integrated neuromuscular inhibition technique to postural correction exercises in patients with cervicogenic headache",[27],[380,381,169],"integrated neuromuscular inhibition technique","postural correction exercises","2025-07-18",{"date":384,"type":44},"2025-07-25",{"date":386,"type":23},"2025-07-30",{"date":388,"type":23},"2026-02-25",{"name":231,"class":51},{"id":391,"slug":392,"hasResults":12,"nctId":393,"briefTitle":394,"officialTitle":395,"acronym":4,"eligibilityCriteria":396,"healthyVolunteers":12,"sex":18,"minAge":397,"maxAge":398,"enrollmentInfo":399,"targetDuration":4,"studyType":64,"phases":401,"briefSummary":402,"conditions":403,"keywords":404,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":408,"lastUpdatePostDateStruct":409,"startDateStruct":411,"completionDateStruct":413,"leadSponsor":415,"locationsCount":52},"100597770","comparing-the-effects-of-sub-occipital-myofascial-release-with-and-without-snag-on-people-with-cervicogenic-dizziness-100597770","NCT07062809","Comparing the Effects of Sub-Occipital Myofascial Release With and Without SNAG on People With Cervicogenic Dizziness.","Comparative Effects of Sub-Occipital Myofascial Release With and Without Sustained Natural Apophyseal Glide Among Patients With Cervicogenic Dizziness.","Inclusion Criteria:\n\n* Cervicogenic dizziness patients both male and female.\n* Age group between 22 to 54 Years old.\n* Passive Accessory Assessment of the UCS (C0-1, C1-2, C2-3).\n* Dizziness related to either movements or positions of the cervical spine, or occurring with a stiff or painful neck.\n* Symptoms \\> 3 months.\n* Moderate disability score on the Dizziness Handicap Inventory (DHI) \\[31-60 points\\] .\n\nExclusion Criteria:\n\n* Conditions for which manual therapy is contraindicated\n* Traumatic brain injury\n* Previous surgery to the upper cervical spine and marked cervical spine disc protrusion\n* By neurologist .Vestibular disorders (e.g. Benign Paroxysmal Positional Vertigo, Meniere's disease, peripheral vestibulopathy)\n\n  * CNS disorder (e.g.cerebellar ataxia, stroke, demyelination)\n  * Migraine associated vertigo\n  * Psychogenic dizziness\n  * Cardiovascular disorders","22 Years","54 Years",{"count":400,"type":23},42,[66],"Cervicogenic dizziness is defined as a sensation of rotation, resulting from an alteration of the neck proprioceptive afferents of the upper cervical spine.Sub-occipital Release, a type of Myofascial Release (MFR) is a form of manual therapy technique which can be used for the treatment of cervicogenic dizziness. Sub-occipital muscles, dura matter and C2 vertebrae are connected to each other through the fascia. Sustained natural apophyseal glides (SNAGs) are also an effective treatment for cervicogenic dizziness. This study aim to determine Comparative Effect of Sub-Occipital Myofascial release with and without Sustained Natural Apophyseal Glide among patients with Cervicogenic Dizziness.",[162,27],[405,406,407],"Cervicogenic Dizziness","Pain","Suboccipital Myofascial Release","2025-07-03",{"date":410,"type":44},"2025-07-14",{"date":412,"type":23},"2025-07-24",{"date":414,"type":23},"2025-10-20",{"name":127,"class":51},{"id":417,"slug":418,"hasResults":12,"nctId":419,"briefTitle":420,"officialTitle":421,"acronym":4,"eligibilityCriteria":422,"healthyVolunteers":12,"sex":18,"minAge":60,"maxAge":156,"enrollmentInfo":423,"targetDuration":4,"studyType":64,"phases":424,"briefSummary":425,"conditions":426,"keywords":431,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":437,"lastUpdatePostDateStruct":438,"startDateStruct":440,"completionDateStruct":442,"leadSponsor":444,"locationsCount":52},"100597449","efficacy-of-adding-greater-occipital-nerve-block-to-trigger-point-injection-in-patients-with-neck-pain-100597449","NCT07058636","Efficacy of Adding Greater Occipital Nerve Block to Trigger Point Injection in Patients With Neck Pain","Evaluation of the Efficacy of Adding Greater Occipital Nerve Block to Trigger Point Injection in Patients With Neck Pain and Upper Trapezius Trigger Points: A Single-Blind Randomized Controlled Trial","Inclusion Criteria:\n\n* Patients aged between 18 and 65 years.\n* Diagnosed with myofascial pain syndrome (MPS) based on the major and minor criteria described by Travell and Simons (a diagnosis requires all 5 major and at least 1 minor criterion)\n* Presence of active trigger points in the upper trapezius muscle.\n* Patients with neck pain lasting longer than 3 months.\n* Pain intensity of ≥5 on the Visual Analog Scale (VAS).\n\nExclusion Criteria:\n\n* Elderly, pediatric, pregnant, postpartum, or breastfeeding individuals; patients in intensive care; unconscious individuals; or legally incapacitated persons.\n* Known allergy to local anesthetics used in trigger point injection (e.g., lidocaine, bupivacaine) or to other drugs used (e.g., corticosteroids).\n* Patients with bleeding disorders (e.g., hemophilia, thrombocytopenia) or those currently on anticoagulant therapy.\n* Presence of active infection at or near the injection site, or any systemic infection; impaired skin integrity.\n* Patients with psychiatric disorders that may interfere with treatment response or affect study outcomes.\n* Patients with severe neurological or cardiovascular disorders, or with uncontrolled diabetes.\n* Patients with cervical disc pathologies with radiculopathy.\n* History of receiving shoulder injection, trigger point injection, dry needling, manual therapy, or electrotherapy within the past 3 months.\n* History of cervical or shoulder surgery.\n* Patients diagnosed with adhesive capsulitis, rotator cuff tendinopathy, or shoulder impingement syndrome.\n* Diagnosis of fibromyalgia.\n* Presence of active trigger points in other back muscles.",{"count":216,"type":23},[66],"Study Title:\n\nEvaluation of the Effectiveness of Adding Greater Occipital Nerve Block to Trigger Point Injection in Patients with Neck Pain Due to Upper Trapezius Trigger Points: A Single-Blind Randomized Controlled Trial\n\nPurpose of the Study:\n\nThis study aims to evaluate whether adding a Greater Occipital Nerve (GON) block to the standard trigger point injection treatment provides better pain relief and improves daily function in patients with neck pain caused by trigger points in the upper trapezius muscle. Trigger points are small, sensitive spots in muscles that can cause significant pain and discomfort. While both trigger point injections and GON blocks are common treatments for neck and head pain, it is not yet clear if combining these two methods offers better results.\n\nWhy is this study important? Neck pain related to trigger points in the upper trapezius muscle is a frequent problem, but there is limited research on the effectiveness of combining trigger point injections with GON blocks. This study will provide important information on whether the combination therapy can reduce pain more effectively and improve patients' quality of life and ability to perform daily activities.\n\nWho can participate?\n\nAdults aged 18 to 65 years old\n\nDiagnosed with myofascial pain syndrome (MAS) based on specific clinical criteria, including the presence of trigger points in the upper trapezius muscle\n\nExperiencing neck pain lasting longer than 3 months\n\nPain intensity rated 5 or higher on a scale of 0 to 10\n\nWho cannot participate?\n\nPregnant or breastfeeding women, children, elderly people, unconscious or critically ill patients\n\nPatients with allergies to local anesthetics or steroids\n\nIndividuals with bleeding disorders or infections near the injection site\n\nPatients with serious psychiatric or neurological diseases, or other medical conditions that may affect study results\n\nThose who have recently received similar treatments or surgery for neck or shoulder problems\n\nStudy Design and Procedures:\n\nThe study will include 60 patients meeting the criteria, randomly assigned to two groups using a balanced randomization method.\n\nGroup A will receive only trigger point injections into the upper trapezius muscle using a mixture of lidocaine and saline solution.\n\nGroup B will receive both trigger point injections and an ultrasound-guided GON block, which involves injecting a combination of local anesthetics and steroid near the greater occipital nerve to reduce pain signals.\n\nBoth groups will receive the same home exercise program focusing on stretching and strengthening neck muscles to support recovery. Patients will be encouraged to perform these exercises regularly and will be followed up weekly by phone to check their progress.\n\nThe doctor assessing patients' progress will not know which treatment the patient received, to ensure unbiased results.\n\nAssessments:\n\nPatients will be evaluated at three different times: before treatment, 1 week after treatment, and 4 weeks after treatment. Assessments include:\n\nPain intensity and quality (using Visual Analog Scale and McGill Pain Questionnaire)\n\nNeck disability and ability to perform daily activities (Neck Disability Index)\n\nQuality of life (Nottingham Health Profile)\n\nNeck joint movement and position sense (using clinical tests with special equipment)\n\nPosture evaluation (measuring head position using photography)\n\nExpected Outcomes:\n\nThe main goal is to determine if the combined treatment of trigger point injection plus GON block is more effective than trigger point injection alone in reducing pain, improving neck function, and enhancing quality of life.\n\nDuration and Follow-Up:\n\nThe study is planned to last 12 months. Patients will be closely monitored during and after treatment to ensure safety and to collect necessary data.\n\nPotential Benefits and Risks:\n\nParticipants may experience pain relief and improved function if the combined treatment is effective. Risks include mild discomfort or side effects related to injections, which will be minimized by experienced medical staff.",[333,427,428,429,430,27],"Myofacial Pain Syndrome","Trigger Point Pain, Myofascial","Trigger Points","Upper Trapezius Trigger Points",[432,433,434,435,436],"neck pain","myofascial pain syndrome","trigger point injection","ultrasound guided occipital nerve block","upper trapezius trigger point","2025-07-01",{"date":439,"type":44},"2025-07-10",{"date":441,"type":44},"2025-04-03",{"date":443,"type":23},"2026-04",{"name":445,"class":206},"Ankara Etlik City Hospital",{"id":447,"slug":448,"hasResults":12,"nctId":449,"briefTitle":450,"officialTitle":450,"acronym":212,"eligibilityCriteria":451,"healthyVolunteers":12,"sex":18,"minAge":374,"maxAge":20,"enrollmentInfo":452,"targetDuration":4,"studyType":64,"phases":453,"briefSummary":454,"conditions":455,"keywords":456,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":458,"lastUpdatePostDateStruct":459,"startDateStruct":461,"completionDateStruct":463,"leadSponsor":465,"locationsCount":4},"100596580","impact-of-adding-jones-technique-to-mulligan-therapy-in-patients-with-cervicogenic-headache-100596580","NCT07047313","Impact of Adding Jones Technique to Mulligan Therapy in Patients With Cervicogenic Headache","Inclusion Criteria:\n\n* 20 to 60 years old patient with unilaterally of the head pain\n* pain triggered by external pressure over the upper cervical joints (c1-c3)\n* pain elicited by the neck movements, and\u002For sustained awkward positions with reduced neck ROM\n* headache intensity pain score of at least 20mm on the Visual analogue scale (VAS)\n* headache frequency of at least once a week for at least 3 months\n* minimum neck disability index score of 10 points or greater\n\nExclusion Criteria:\n\n* Migraine, tension- type headache, tumor, osteoporosis, fracture, rheumatoid arthritis and metabolic diseases.\n* Prolonged history of steroid use.\n* Resting blood pressure greater than 140\u002F90 mmhg.\n* cervical spinal stenosis, diminished sensation and central nervous system involvement,\n* previous head or neck surgery or whiplash injury history within the last 6 weeks",{"count":186,"type":23},[66],"this study will be conducted to investigate impact of adding jones technique to mulligan therapy in patients with cervicogenic headache",[27],[457,222,169],"jones technique","2025-06-24",{"date":460,"type":44},"2025-07-02",{"date":462,"type":23},"2025-06-30",{"date":464,"type":23},"2026-01-30",{"name":231,"class":51},{"id":467,"slug":468,"hasResults":12,"nctId":469,"briefTitle":470,"officialTitle":470,"acronym":4,"eligibilityCriteria":471,"healthyVolunteers":12,"sex":18,"minAge":60,"maxAge":472,"enrollmentInfo":473,"targetDuration":4,"studyType":64,"phases":475,"briefSummary":476,"conditions":477,"keywords":4,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":478,"lastUpdatePostDateStruct":479,"startDateStruct":481,"completionDateStruct":483,"leadSponsor":485,"locationsCount":52},"100593439","comparison-of-ventro-cephalic-to-dorso-caudal-translatoric-glides-in-management-of-cervicogenic-headache-100593439","NCT07006454","Comparison of Ventro-Cephalic to Dorso-Caudal Translatoric Glides in Management of Cervicogenic Headache","Inclusion Criteria:\n\n* • Age 18 to 44 years old\n\n  * Both male and female A- Any headache fulling criterion C. B- Clinical and\u002For imaging evidence of lesion or disorder in cervical spine or soft tissues of neck that can cause headache.\n\nC- Evidence of cause of headache demonstrated by at least 2 of these:\n\n1. headache has developed in temporal relation to the onset of the cervical disorder or lesion.\n2. headache has significantly improved or resolved in parallel with improvement in cervical lesion or disorder.\n3. cervical range of motion is reduced, and headache is made significantly worse by provocative maneuvers.\n4. headache is abolished following diagnostic blocked of cervical structure. D- Not better accounted for by another ICHD-3 diagnosis\n\nExclusion Criteria:\n\n* 1- Tension-type headaches and migraine 2- History of Vertigo or Dizziness 3- Already taking manual therapy treatment 4- Prior surgery to the head and neck 5- Trauma","44 Years",{"count":474,"type":23},40,[66],"This study is a randomised control trial and the purpose of this study is to compare ventro-cephalic to dorso-caudal translatoric glides in management of cervicogenic headache.",[27],"2025-06-13",{"date":480,"type":44},"2025-06-16",{"date":482,"type":44},"2024-07-18",{"date":484,"type":23},"2025-06-20",{"name":147,"class":51},{"id":487,"slug":488,"hasResults":12,"nctId":489,"briefTitle":490,"officialTitle":491,"acronym":4,"eligibilityCriteria":492,"healthyVolunteers":12,"sex":18,"minAge":60,"maxAge":156,"enrollmentInfo":493,"targetDuration":4,"studyType":64,"phases":495,"briefSummary":496,"conditions":497,"keywords":499,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":501,"lastUpdatePostDateStruct":502,"startDateStruct":504,"completionDateStruct":506,"leadSponsor":507,"locationsCount":52},"100554735","manipulation-and-dry-needling-in-patients-with-cervicogenic-headache-and-wad-ii-100554735","NCT06502951","Manipulation and Dry Needling in Patients With Cervicogenic Headache and WAD II","Upper Cervical Spine Manipulation and Dry Needling Versus Conventional Physical Therapy in Patients With Cervicogenic Headache and Type II Whiplash Associated Disorder: a Multi-center Randomized Clinical Trial","Inclusion Criteria:\n\n1. Subacute (\\> 4 weeks) or chronic type II whiplash associated disorder. Neck pain and headache following motor vehicle accident with reduced range of motion \\& point tenderness.\n2. Diagnosis of cervicogenic headache as defined by Cervicogenic Headache International Study Group criteria.\n3. Headache frequency of at least one per week since the whiplash injury.\n4. Headache intensity of greater than 2\u002F10 on the NPRS.\n5. Neck pain intensity of greater than 2\u002F10 on the NPRS.\n6. Neck Disability Index score of greater than 10\u002F50 on the NDI.\n\nExclusion Criteria:\n\n1. WAD I (neck pain, but no physical signs), WAD III (neck pain and neurological signs), WAD IV (neck pain + fracture\u002Fdislocation).\n2. Positive screen for cervical radiography (Canadian C-Spine Rules).\n3. Bilateral headaches (typical of tension type headaches).\n4. Diagnosis \u002F signs \\& symptoms of concussion (confusion, disorientation, or impaired consciousness; loss of memory for events immediately before or after the MVA; and one or more of the following: nausea, vomiting, visual disturbances, vertigo, gait and\u002For postural imbalance, and impaired memory and\u002For concentration).\n5. Diagnosis of fibromyalgia.\n6. Presence of any of the following atherosclerotic risk factors: hypertension, diabetes, heart disease, stroke, transient ischemic attack, peripheral vascular disease, smoking, hypercholesterolemia, or hyperlipidemia.\n7. Red flags noted in the patient's Neck Medical Screening Questionnaire (i.e., tumor, fracture, metabolic diseases, RA, osteoporosis, prolonged history of steroid use, etc.).\n8. Diagnosis of cervical spinal stenosis.\n9. Bilateral upper extremity symptoms.\n10. Evidence of central nervous system involvement, to include hyperreflexia, sensory disturbances in the hand, intrinsic muscle wasting of the hands, unsteadiness during walking, nystagmus, loss of visual acuity, impaired sensation of the face, altered taste, the presence of pathological reflexes (i.e. positive Hoffman's and\u002For Babinski reflexes).\n11. Two or more positive neurologic signs consistent with nerve root compression, including any two of the following:\n\n    1. Muscle weakness involving a major muscle group of the upper extremity.\n    2. Diminished upper extremity deep tendon reflex of the biceps, brachioradialis, triceps or superficial flexors\n    3. Diminished or absent sensation to pinprick in any UE dermatome.\n12. Prior surgery to the head, neck, or thoracic spine.\n13. Physical therapy or chiropractic treatment for neck pain and\u002For headache in the past 3 months.\n14. Any condition that might contraindicate spinal manipulative therapy or dry needling.",{"count":494,"type":23},120,[66],"The purpose of this research is to compare two different approaches for treating patients with cervicogenic headaches associated with type II whiplash associated disorder: non-thrust mobilization and exercise versus thrust manipulation and dry needling. Physical therapists commonly use all of these techniques to treat cervicogenic headaches. This study is attempting to find out if one treatment strategy is more effective than the other.",[27,498],"Whiplash Injuries",[94,500],"Whiplash","2025-05-07",{"date":503,"type":44},"2025-05-11",{"date":505,"type":44},"2024-07-20",{"date":174,"type":23},{"name":508,"class":51},"Alabama Physical Therapy & Acupuncture",{"id":510,"slug":511,"hasResults":12,"nctId":512,"briefTitle":513,"officialTitle":514,"acronym":4,"eligibilityCriteria":515,"healthyVolunteers":12,"sex":18,"minAge":19,"maxAge":516,"enrollmentInfo":517,"targetDuration":4,"studyType":64,"phases":518,"briefSummary":519,"conditions":520,"keywords":521,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":527,"lastUpdatePostDateStruct":528,"startDateStruct":530,"completionDateStruct":532,"leadSponsor":533,"locationsCount":52},"100583403","ischemic-compression-technique-versus-jones-technique-in-cervicogenic-headache-patients-100583403","NCT06875869","Ischemic Compression Technique Versus Jones Technique in Cervicogenic Headache Patients","Comparative Effects of Jones and Ischemic Compression Technique on Pain, Range of Motion and Disability in Patients With Cervicogenic Headache","Inclusion Criteria:\n\n* Both males and females\n* 25-35 years of age\n* Individuals satisfying the Cervicogenic Headache criteria\n* Positive Simon's criteria for trigger points\n\nExclusion Criteria:\n\n* primary headaches (i.e., migraine, tension type headache)\n* bilateral headache\n* Presence of any red flags\n* cervical spinal stenosis\n* evidence of central nervous system involvement\n* prior surgery to the head or neck","35 Years",{"count":63,"type":23},[66],"The primary objective of the study is to determine the effects of Jones and Ischemic compression technique on pain, range of motion and disability in patients with cervicogenic headache. Cervicogenic headache is a distinctive type of secondary headache where the pain originates from structures in the neck or cervical spine and radiates to the head. Trigger point release has been associated with decrease in symptoms of patients with cervicogenic headache. This study will be a randomized clinical trial with the sample size of 32 patients. Participants will be randomly allocated into two groups: Group A and Group B. The setting of the study will be Bahawal Victoria Hospital, Bahawalpur. Group A will receive Jones technique of trigger points of the upper trapezius and sternocleidomastoid muscle while Group B will receive ischemic compression of the trigger points of the upper trapezius and sternocleidomastoid muscle. Patients of both groups will receive two treatment sessions per week for 6 weeks. Both groups will receive hot pack for 10 minutes, TENS for 15 minutes and strengthening exercises for deep neck flexors (chin tuck and head raise with ten repetitions of 10-second duration, with a 10-second rest interval between each contraction) as baseline treatment protocol. NPRS, HDI and FRT will be used as outcome measure tools. Data will be analyzed using SPSS version 25.0 with the p-value of \\\u003C0.05 taken as significant difference.",[27],[95,522,523,524,525,526],"Disability evaluation","Ischemic compression therapy","Pain assessment","Range of motion","Trigger point","2025-03-10",{"date":529,"type":44},"2025-03-13",{"date":531,"type":44},"2025-01-02",{"date":334,"type":23},{"name":127,"class":51},{"id":535,"slug":536,"hasResults":12,"nctId":537,"briefTitle":538,"officialTitle":538,"acronym":539,"eligibilityCriteria":540,"healthyVolunteers":12,"sex":18,"minAge":374,"maxAge":20,"enrollmentInfo":541,"targetDuration":4,"studyType":64,"phases":543,"briefSummary":544,"conditions":545,"keywords":546,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":549,"lastUpdatePostDateStruct":550,"startDateStruct":552,"completionDateStruct":554,"leadSponsor":556,"locationsCount":4},"100578474","comparative-effects-of-strain-counterstrain-and-muscle-energy-techniques-on-neck-pain-and-functional-disability-in-patients-with-cervicogenic-headache-100578474","NCT06811766","Comparative Effects of Strain-counterstrain and Muscle Energy Techniques on Neck Pain and Functional Disability in Patients with Cervicogenic Headache","SCS METs","Inclusion Criteria:\n\n* participants who fulfill the criteria of international headache society.\n\nExclusion Criteria:\n\n* participants who have cervicogenic headache after cervical injury or head surgery.",{"count":542,"type":23},54,[66],"The primary objective of this study is to compare effects of SCS and METs on reduction of neck pain intensity and improvement in functional disability in individuals with CGH. The secondary objective is to assess the impact of both techniques on ROM in cervical spine",[27],[212,547,548],"SCS","METs","2025-01-31",{"date":551,"type":44},"2025-02-06",{"date":553,"type":23},"2025-02",{"date":555,"type":23},"2025-09",{"name":557,"class":51},"University of Faisalabad",{"id":559,"slug":560,"hasResults":12,"nctId":561,"briefTitle":562,"officialTitle":563,"acronym":4,"eligibilityCriteria":564,"healthyVolunteers":12,"sex":18,"minAge":565,"maxAge":238,"enrollmentInfo":566,"targetDuration":4,"studyType":64,"phases":567,"briefSummary":568,"conditions":569,"keywords":4,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":549,"lastUpdatePostDateStruct":570,"startDateStruct":572,"completionDateStruct":573,"leadSponsor":575,"locationsCount":52},"100577814","high-power-laser-on-suboccipital-myoelectrical-activities-and-quality-of-life-in-patients-with-cervicogenic-headache-100577814","NCT06803186","High Power Laser on Suboccipital Myoelectrical Activities and Quality of Life in Patients With Cervicogenic Headache","Effect of High Power Laser Therapy on Myoelectrical Activities of Suboccipital Muscles and Quality of Life in Patients With Cervicogenic Headache","Inclusion Criteria:\n\n* Patients suffering from cervicogenic headache based on international headache society \"IHS\" criteria for cervicogenic headache.\n* Unilateral cervical radiculopathy (Upper cervical C1 -C4).\n* Age ranged from 30 to 50 years.\n* Neck pain referring unilaterally to suboccipital region.\n* The pain and restriction in C1-C2 rotation by Cervical Flexion-Rotation Test (FRT )\n* Intensifying headache by manual pressure to upper cervical muscles and joints.\n* Experiencing headache at least once per week for the last 6 months.\n* Patients will be referred by neurological consultants.\n* Body mass index (18.5 - 29. 9 Kg\u002Fm2).\n* Moderate (45-74) to severe (75-100) neck pain on the visual analogue scale.\n\nExclusion Criteria:\n\n* Cervical myelopathy, cervical instability, cervical fracture cervical surgery with evidence of pyramidal, posterior column disorders.\n* History of any neurologic disease ( stroke, MS , cerebellar disorders , vestibular dysfunction and neuropathy )Pregnant or breastfeeding women\n* Other types of headaches (migraine - cluster headaches- tension headache)\n* Patients of systemic diseases such as rheumatoid arthritis\n* contraindication to high-power Laser such as:\n* Wounds or skin changes in the neck or shoulder region (such as psoriasis, scars, or burns).\n* Photosensitivity diagnosis.\n* Tumors of some type have been diagnosed in the last 5 years.\n* Presence of solar urticaria or adverse reactions to sunlight.","30 Years",{"count":474,"type":23},[66],"The study will be conducted:\n\nTo investigate the effect of high-power laser on myoelectrical activities of suboccipital muscles in patients with cervicogenic headache.\n\n* To investigate the effect of high-power laser on pain in patients with cervicogenic headache.\n* To investigate the effect of high-power laser on quality of life in patients with cervicogenic headache.",[27],{"date":571,"type":44},"2025-02-04",{"date":549,"type":23},{"date":574,"type":23},"2025-05-15",{"name":231,"class":51},{"id":577,"slug":578,"hasResults":12,"nctId":579,"briefTitle":580,"officialTitle":581,"acronym":4,"eligibilityCriteria":582,"healthyVolunteers":12,"sex":18,"minAge":60,"maxAge":19,"enrollmentInfo":583,"targetDuration":4,"studyType":24,"phases":4,"briefSummary":585,"conditions":586,"keywords":4,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":587,"lastUpdatePostDateStruct":588,"startDateStruct":590,"completionDateStruct":592,"leadSponsor":594,"locationsCount":52},"100417992","relation-between-cervicogenic-headache-and-forward-head-posture-100417992","NCT04722913","Relation Between Cervicogenic Headache and Forward Head Posture","Cervicogenic Headache Among Subjects With Forward Head Posture: a Correlational Cross-sectional Study.","Inclusion Criteria:\n\n1. Subjects with Craniovertebral angle (CVA) less than 50 degrees. (Gavin Morrison, 2018).\n2. University students who were taking consecutive lectures for 3 hours and who worked forward for 3 hours or more on laptop (Arfa Naz et al, 2018).\n\nExclusion Criteria:\n\n1. History of significant medical conditions that might be potential contraindications to physical examination of the cervical spine, including known cancer, osteoporosis, nerve root symptoms, inflammatory or infectious diseases affecting the neck instability of the cervical spine, or reported potential vertebrobasilar insufficiency symptoms (Peter K. Farmer et al, 2015).\n2. History of cervical spine injures (fracture, sprain, strain, whiplash), cervical spondylosis, obvious spinal deformities, neurological and neuromuscular disorders, TMJ dysfunction, cervicothoracic and lumbar kyphoscoliosis, rheumatic disease, torticollis, and balance disorders (B. Shaghayegh fard et al, 2015).",{"count":584,"type":23},400,"This study will be designed to determining whether there is a relationship between CGH and cervical posture which may potentially provide physical therapists with evidence supporting the assessment and treatment of abnormal posture in this patient group.",[27],"2025-01-16",{"date":589,"type":44},"2025-01-20",{"date":591,"type":44},"2024-12-10",{"date":593,"type":23},"2025-02-15",{"name":231,"class":51},{"id":596,"slug":597,"hasResults":12,"nctId":598,"briefTitle":599,"officialTitle":599,"acronym":4,"eligibilityCriteria":600,"healthyVolunteers":12,"sex":18,"minAge":60,"maxAge":61,"enrollmentInfo":601,"targetDuration":4,"studyType":64,"phases":602,"briefSummary":603,"conditions":604,"keywords":4,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":605,"lastUpdatePostDateStruct":606,"startDateStruct":608,"completionDateStruct":610,"leadSponsor":612,"locationsCount":52},"100572272","additional-effects-of-sternocleidomastoid-release-along-with-suboccipital-muscle-release-in-management-of-cervicogenic-headache-100572272","NCT06731114","\"Additional Effects of Sternocleidomastoid Release Along With Suboccipital Muscle Release in Management of Cervicogenic Headache'","Inclusion Criteria\n\n* Participants will be included according to international classification of headache criteria which includes:\n* Headache with neck stiffness\n* Headache at least once a month in the last 3 months\n* Headache with at least 4 score in Numeric Pain Rating Scale(NPRS)\n* Unilateral headache with no shift of side\n* Positive flexion rotation test (Rotation restriction is greater than 10 degrees)\n* C1-C2 dysfunction\n* Headache precipitated by sustained neck movements,myofacial trigger points palpation in neck\n* Age group 18-45\n* Both male and female\n\nExclusion Criteria:\n\n* Cervical spondylosis\n* Headache of non-cervical origin\n* Dizziness or visual disturbance\n* Cervical radiculopathy\u002F nerve root involvement\u002F disc herniation\n* Cervical instability\u002F fracture\n* Vertebrobasilar insufficiency\n* Thoracic outlet syndrome\n* Cervical spine surgery\n* Cervical spondylolisthesis\n* Spinal infection or tumors\n* Osteoporosis\n* meningitis\n* subarachnoid hemorrhage",{"count":542,"type":23},[66],"This study is a randomised control trial and the purpose of this study is to determine the \"Additional effects of sternocleidomastoid release along with suboccipital muscle release in management of cervicogenic headache\".",[27],"2024-12-09",{"date":607,"type":44},"2024-12-12",{"date":609,"type":44},"2024-07-15",{"date":611,"type":23},"2025-07-15",{"name":147,"class":51}]